Lifecore Biomedical, Inc. De (LFCR) Total Current Liabilities (2011 - 2025)

Lifecore Biomedical's Total Current Liabilities history runs 15 years deep, the most recent figure standing at $30.2 million for Q2 2025.

• In Q2 2025, Total Current Liabilities fell 22.37% year-over-year to $30.2 million; the TTM figure through May 2025 stood at $30.2 million (down 22.37% YoY), while the FY2025 annual figure was $30.2 million, down 22.37% from the prior year.
• Total Current Liabilities was $30.2 million for Q2 2025 at Lifecore Biomedical, down from $31.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $195.6 million in Q4 2022 to a low of $30.2 million in Q2 2025.
• Historically, Total Current Liabilities has averaged $81.1 million across 5 years, with a median of $40.4 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities surged 73.37% in 2022, then slumped 80.19% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $122.4 million in 2021, then surged by 59.83% to $195.6 million in 2022, then tumbled by 79.42% to $40.3 million in 2023, then retreated by 12.33% to $35.3 million in 2024, then declined by 14.49% to $30.2 million in 2025.
• The last three Total Current Liabilities figures came in at $30.2 million (Q2 2025), $31.1 million (Q1 2025), and $35.3 million (Q4 2024), per Business Quant data.